Moreover, our study found that lower levels of CMTM5 expression were related to lower RFS in luminal A and basal-like subtypes, but not in luminal B and HER2+ subtype, which indicated that this was also present with tumor heterogeneity in the CMTM5 expression. Here, ERBB2 is linked to neoplasm.